IBDEI0EJ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6688,1,4,0)
 ;;=4^Z85.828
 ;;^UTILITY(U,$J,358.3,6688,2)
 ;;=^5063443
 ;;^UTILITY(U,$J,358.3,6689,0)
 ;;=Z85.71^^30^397^78
 ;;^UTILITY(U,$J,358.3,6689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6689,1,3,0)
 ;;=3^Personal Hx of Hodgkin Lymphoma
 ;;^UTILITY(U,$J,358.3,6689,1,4,0)
 ;;=4^Z85.71
 ;;^UTILITY(U,$J,358.3,6689,2)
 ;;=^5063435
 ;;^UTILITY(U,$J,358.3,6690,0)
 ;;=Z65.8^^30^397^138
 ;;^UTILITY(U,$J,358.3,6690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6690,1,3,0)
 ;;=3^Psychosocial Circumstance Related Problems
 ;;^UTILITY(U,$J,358.3,6690,1,4,0)
 ;;=4^Z65.8
 ;;^UTILITY(U,$J,358.3,6690,2)
 ;;=^5063185
 ;;^UTILITY(U,$J,358.3,6691,0)
 ;;=Z86.11^^30^397^115
 ;;^UTILITY(U,$J,358.3,6691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6691,1,3,0)
 ;;=3^Personal Hx of Tuberculosis
 ;;^UTILITY(U,$J,358.3,6691,1,4,0)
 ;;=4^Z86.11
 ;;^UTILITY(U,$J,358.3,6691,2)
 ;;=^5063461
 ;;^UTILITY(U,$J,358.3,6692,0)
 ;;=Z86.13^^30^397^82
 ;;^UTILITY(U,$J,358.3,6692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6692,1,3,0)
 ;;=3^Personal Hx of Malaria
 ;;^UTILITY(U,$J,358.3,6692,1,4,0)
 ;;=4^Z86.13
 ;;^UTILITY(U,$J,358.3,6692,2)
 ;;=^5063463
 ;;^UTILITY(U,$J,358.3,6693,0)
 ;;=Z86.73^^30^397^112
 ;;^UTILITY(U,$J,358.3,6693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6693,1,3,0)
 ;;=3^Personal Hx of TIA & Cereb Infrc w/o Residual Deficits
 ;;^UTILITY(U,$J,358.3,6693,1,4,0)
 ;;=4^Z86.73
 ;;^UTILITY(U,$J,358.3,6693,2)
 ;;=^5063477
 ;;^UTILITY(U,$J,358.3,6694,0)
 ;;=Z86.79^^30^397^75
 ;;^UTILITY(U,$J,358.3,6694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6694,1,3,0)
 ;;=3^Personal Hx of Circulatory System Diseases
 ;;^UTILITY(U,$J,358.3,6694,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,6694,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,6695,0)
 ;;=Z91.040^^30^397^64
 ;;^UTILITY(U,$J,358.3,6695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6695,1,3,0)
 ;;=3^Latex Allergy Status
 ;;^UTILITY(U,$J,358.3,6695,1,4,0)
 ;;=4^Z91.040
 ;;^UTILITY(U,$J,358.3,6695,2)
 ;;=^5063607
 ;;^UTILITY(U,$J,358.3,6696,0)
 ;;=Z98.89^^30^397^120
 ;;^UTILITY(U,$J,358.3,6696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6696,1,3,0)
 ;;=3^Postprocedural States/Hx of Surgery NEC
 ;;^UTILITY(U,$J,358.3,6696,1,4,0)
 ;;=4^Z98.89
 ;;^UTILITY(U,$J,358.3,6696,2)
 ;;=^5063754
 ;;^UTILITY(U,$J,358.3,6697,0)
 ;;=Z92.3^^30^397^79
 ;;^UTILITY(U,$J,358.3,6697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6697,1,3,0)
 ;;=3^Personal Hx of Irradiation
 ;;^UTILITY(U,$J,358.3,6697,1,4,0)
 ;;=4^Z92.3
 ;;^UTILITY(U,$J,358.3,6697,2)
 ;;=^5063637
 ;;^UTILITY(U,$J,358.3,6698,0)
 ;;=Z91.120^^30^397^60
 ;;^UTILITY(U,$J,358.3,6698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6698,1,3,0)
 ;;=3^Intentional Underdose of Meds d/t Financial Hardship
 ;;^UTILITY(U,$J,358.3,6698,1,4,0)
 ;;=4^Z91.120
 ;;^UTILITY(U,$J,358.3,6698,2)
 ;;=^5063612
 ;;^UTILITY(U,$J,358.3,6699,0)
 ;;=Z91.11^^30^397^69
 ;;^UTILITY(U,$J,358.3,6699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6699,1,3,0)
 ;;=3^Noncompliance w/ Dietary Regimen
 ;;^UTILITY(U,$J,358.3,6699,1,4,0)
 ;;=4^Z91.11
 ;;^UTILITY(U,$J,358.3,6699,2)
 ;;=^5063611
 ;;^UTILITY(U,$J,358.3,6700,0)
 ;;=Z87.891^^30^397^103
 ;;^UTILITY(U,$J,358.3,6700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6700,1,3,0)
 ;;=3^Personal Hx of Nicotine Dependence
 ;;^UTILITY(U,$J,358.3,6700,1,4,0)
 ;;=4^Z87.891
 ;;^UTILITY(U,$J,358.3,6700,2)
 ;;=^5063518
 ;;^UTILITY(U,$J,358.3,6701,0)
 ;;=Z77.090^^30^397^11
 ;;^UTILITY(U,$J,358.3,6701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6701,1,3,0)
 ;;=3^Asbestos Contact/Exposure
 ;;^UTILITY(U,$J,358.3,6701,1,4,0)
 ;;=4^Z77.090
